Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
Logo Image
|Articles|August 13, 2010

Clearstone Central Laboratories and LabCorp Establish Global Strategic Collaboration for Clinical Trials

Clearstone Central Laboratories

announced a global collaboration with Laboratory Corporation of America® Holdings (LabCorp®) through its Esoterix Clinical Trials Services division, providing clients with access to CAP-accredited laboratories across both organizations in Belgium, Canada, China, France, Singapore and the United States.  This global collaboration will deliver safety, diagnostic and specialty testing services in support of drug development and clinical trials. In addition, clients of each company will be able to access LabCorp’s industry-leading assay portfolio and Clearstone’s central laboratory protocol management system APOLLO CLPM™.
 

Related to this article

View more
Where AI Leads in Trial Design—and Where Humans Still Need To
Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.
Read more